Skip to main content
VCbacked
Log inGet Started

Valo Therapeutics

Helsinki, Finland

Valo Therapeutics is an immunotherapy company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.

$20.6M raised
Mar 2025
Venture - Series Unknown
BiotechnologyHealth CareMedicalOncologyTherapeutics

Top Investors

CDP Venture CapitalEuropean Innovation CouncilBusiness FinlandIndaco Venture PartnersENEA Tech e Biomedical

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Valo Therapeutics

How much funding has Valo Therapeutics raised?
Valo Therapeutics has raised $20.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
Who are Valo Therapeutics's investors?
Valo Therapeutics's investors include CDP Venture Capital, European Innovation Council, Business Finland, Indaco Venture Partners, ENEA Tech e Biomedical.
Where is Valo Therapeutics headquartered?
Valo Therapeutics is headquartered in Helsinki, Finland.
What does Valo Therapeutics do?
Valo Therapeutics is an immunotherapy company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
What stage is Valo Therapeutics at?
Valo Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Valo Therapeutics — Funding & Investors." VCBacked, March 10, 2025, https://www.vcbacked.co/company/valo-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). Valo Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/valo-therapeutics
Wikipedia (cite web)
{{cite web |title=Valo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/valo-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong